Targeting MET Amplification as a New Oncogenic Driver

por Kawakami, Hisato, Okamoto, Isamu, Okamoto, Wataru, Tanizaki, Junko, Nakagawa, Kazuhiko, Nishio, Kazuto
Publicado 2014

Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumab

por Kato, Ryoji, Hayashi, Hidetoshi, Tanizaki, Junko, Tanaka, Kaoru, Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado 2017

Regression of brain metastases from breast cancer with eribulin: a case report

por Matsuoka, Hiromichi, Tsurutani, Junji, Tanizaki, Junko, Iwasa, Tsutomu, Komoike, Yoshifumi, Koyama, Atsuko, Nakagawa, Kazuhiko
Publicado 2013

Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of EGFR or HER2

por Takeda, Masayuki, Sakai, Kazuko, Hayashi, Hidetoshi, Tanaka, Kaoru, Tanizaki, Junko, Takahama, Takayuki, Haratani, Koji, Nishio, Kazuto, Nakagawa, Kazuhiko
Publicado 2018

A case of ALK-rearranged non–small cell lung cancer that responded to ceritinib after development of resistance to alectinib

por Makuuchi, Yosuke, Hayashi, Hidetoshi, Haratani, Koji, Tanizaki, Junko, Tanaka, Kaoru, Takeda, Masayuki, Sakai, Kazuko, Shimizu, Shigeki, Ito, Akihiko, Nishio, Kazuto, Nakagawa, Kazuhiko
Publicado 2018

Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer

por Watanabe, Satomi, Yonesaka, Kimio, Tanizaki, Junko, Nonagase, Yoshikane, Takegawa, Naoki, Haratani, Koji, Kawakami, Hisato, Hayashi, Hidetoshi, Takeda, Masayuki, Tsurutani, Junji, Nakagawa, Kazuhiko
Publicado 2019

A case of sarcomatoid malignant peritoneal mesothelioma diagnosed by laparoscopy

por Kobayashi, Mariya, Masuda, Kumi, Noda, Yuri, Tanizaki, Junko, Yamabe, Eri, Tanaka, Asuka, Koumura, Naoko, Kozasa, Katsumi, Naoi, Hirokazu, Otsuka, Hirohumi, Yokoi, Takeshi
Publicado 2020

Clinical implications of bronchoscopy for immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer

por Nishiyama, Osamu, Shimizu, Shigeki, Haratani, Koji, Isomoto, Kosuke, Tanizaki, Junko, Hayashi, Hidetoshi, Yamazaki, Ryo, Oomori, Takashi, Nishikawa, Yusaku, Sano, Akiko, Nakagawa, Kazuhiko, Tohda, Yuji
Publicado 2021

Mutational activation of the epidermal growth factor receptor down‐regulates major histocompatibility complex class I expression via the extracellular signal‐regulated kinase in no...

por Watanabe, Satomi, Hayashi, Hidetoshi, Haratani, Koji, Shimizu, Shigeki, Tanizaki, Junko, Sakai, Kazuko, Kawakami, Hisato, Yonesaka, Kimio, Tsurutani, Junji, Togashi, Yosuke, Nishio, Kazuto, Ito, Akihiko, Nakagawa, Kazuhiko
Publicado 2018

Phase I study of weekly nab-paclitaxel combined with S-1 in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer

por Tsurutani, Junji, Kuroi, Katsumasa, Iwasa, Tsutomu, Miyazaki, Masaki, Nishina, Shinichi, Makimura, Chihiro, Tanizaki, Junko, Okamoto, Kunio, Yamashita, Toshinari, Aruga, Tomoyuki, Shigekawa, Takashi, Komoike, Yoshifumi, Saeki, Toshiaki, Nakagawa, Kazuhiko
Publicado 2015

Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1

por Nonagase, Yoshikane, Yonesaka, Kimio, Kawakami, Hisato, Watanabe, Satomi, Haratani, Koji, Takahama, Takayuki, Takegawa, Naoki, Ueda, Hiroto, Tanizaki, Junko, Hayashi, Hidetoshi, Yoshida, Takeshi, Takeda, Masayuki, Chiba, Yasutaka, Tamura, Takao, Nakagawa, Kazuhiko, Tsurutani, Junji
Publicado 2016

Clinical and immune profiling for cancer of unknown primary site

por Haratani, Koji, Hayashi, Hidetoshi, Takahama, Takayuki, Nakamura, Yasushi, Tomida, Shuta, Yoshida, Takeshi, Chiba, Yasutaka, Sawada, Takahiro, Sakai, Kazuko, Fujita, Yoshihiko, Togashi, Yosuke, Tanizaki, Junko, Kawakami, Hisato, Ito, Akihiko, Nishio, Kazuto, Nakagawa, Kazuhiko
Publicado 2019

FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib

por Hibi, Masaaki, Kaneda, Hiroyasu, Tanizaki, Junko, Sakai, Kazuko, Togashi, Yosuke, Terashima, Masato, De Velasco, Marco Antonio, Fujita, Yoshihiko, Banno, Eri, Nakamura, Yu, Takeda, Masayuki, Ito, Akihiko, Mitsudomi, Tetsuya, Nakagawa, Kazuhiko, Okamoto, Isamu, Nishio, Kazuto
Publicado 2016

Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors

por Yonesaka, Kimio, Iwama, Eiji, Hayashi, Hidetoshi, Suzuki, Shinichiro, Kato, Ryoji, Watanabe, Satomi, Takahama, Takayuki, Tanizaki, Junko, Tanaka, Kaoru, Takeda, Masayuki, Sakai, Kazuko, Azuma, Koichi, Chiba, Yasutaka, Atagi, Shinji, Nishio, Kazuto, Okamoto, Isamu, Nakagawa, Kazuhiko
Publicado 2019

Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L

por Sakata, Shinya, Otsubo, Kohei, Yoshida, Hisako, Ito, Kentaro, Nakamura, Atsushi, Teraoka, Shunsuke, Matsumoto, Naohisa, Shiraishi, Yoshimasa, Haratani, Koji, Tamiya, Motohiro, Ikeda, Satoshi, Miura, Satoru, Tanizaki, Junko, Omori, Shota, Yoshioka, Hiroshige, Hata, Akito, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Publicado 2021

The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLC

por Kanemura, Hiroaki, Hayashi, Hidetoshi, Tomida, Shuta, Tanizaki, Junko, Suzuki, Shinichiro, Kawanaka, Yusuke, Tsuya, Asuka, Fukuda, Yasushi, Kaneda, Hiroyasu, Kudo, Keita, Takahama, Takayuki, Imai, Ryosuke, Haratani, Koji, Chiba, Yasutaka, Otani, Tomoyuki, Ito, Akihiko, Sakai, Kazuko, Nishio, Kazuto, Nakagawa, Kazuhiko
Publicado 2022

A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L)

por Hayashi, Hidetoshi, Sugawara, Shunichi, Fukuda, Yasushi, Fujimoto, Daichi, Miura, Satoru, Ota, Keiichi, Ozawa, Yuichi, Hara, Satoshi, Tanizaki, Junko, Azuma, Koichi, Omori, Shota, Tachihara, Motoko, Nishino, Kazumi, Bessho, Akihiro, Chiba, Yasutaka, Haratani, Koji, Sakai, Kazuko, Nishio, Kazuto, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Publicado 2022

Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain

por Fujita, Yoshihiko, Matsuoka, Hiromichi, Chiba, Yasutaka, Tsurutani, Junji, Yoshida, Takeshi, Sakai, Kiyohiro, Nakura, Miki, Sakamoto, Ryo, Makimura, Chihiro, Ohtake, Yoichi, Tanaka, Kaoru, Hayashi, Hidetoshi, Takeda, Masayuki, Okuno, Tatsuya, Takegawa, Naoki, Haratani, Koji, Takahama, Takayuki, Tanizaki, Junko, Koyama, Atsuko, Nishio, Kazuto, Nakagawa, Kazuhiko
Publicado 2023

Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer

por Masuda, Takeshi, Miura, Satoru, Sato, Yuki, Tachihara, Motoko, Bessho, Akihiro, Nakamura, Atsushi, Miyawaki, Taichi, Yoshimine, Kohei, Mori, Masahide, Shiraishi, Hideaki, Hamai, Kosuke, Haratani, Koji, Maeda, Sumiko, Tabata, Eriko, Kitagawa, Chiyoe, Tanizaki, Junko, Imai, Takumi, Nogami, Shohei, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko, Hattori, Noboru
Publicado 2023

A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC

por Fujimoto, Daichi, Miura, Satoru, Yoshimura, Kenichi, Wakuda, Kazushige, Oya, Yuko, Haratani, Koji, Itoh, Shoichi, Uemura, Takehiro, Morinaga, Ryotaro, Takahama, Takayuki, Nakashima, Kazuhisa, Tachihara, Motoko, Saito, Go, Tanizaki, Junko, Otsubo, Kohei, Ikeda, Satoshi, Matsumoto, Hirotaka, Hara, Satoshi, Hata, Akito, Masuda, Takeshi, Yamamoto, Nobuyuki
Publicado 2021